Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,173,804
-
Share change
-
-2,110,962
-
Total reported value
-
$135,952,961
-
Put/Call ratio
-
315%
-
Price per share
-
$4.66
-
Number of holders
-
113
-
Value change
-
-$21,397,465
-
Number of buys
-
65
-
Number of sells
-
64
Institutional Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q4 2021
As of 31 Dec 2021,
TCR2 THERAPEUTICS INC - COM (TCRR) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,173,804 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, BIOIMPACT CAPITAL LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Redmile Group, LLC, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
113
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.